一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

p63 (phospho Ser395)兔多抗,p63 (phospho Ser395) Rabbit Polyclonal Antibody
  • p63 (phospho Ser395)兔多抗,p63 (phospho Ser395) Rabbit Polyclonal Antibody

p63 (phospho Ser395) Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩璣生命

價(jià)格 詢價(jià)
包裝 1支
最小起訂量 1支
發(fā)貨地 湖北
更新日期 2026-05-06
微信洽談

產(chǎn)品詳情

中文名稱:p63 (phospho Ser395)兔多抗英文名稱:p63 (phospho Ser395) Rabbit Polyclonal Antibody
品牌: EnkiLife產(chǎn)地: 中國
產(chǎn)品類別: 抗體
是否進(jìn)口: 用途: 科研
2026-05-06 p63 (phospho Ser395)兔多抗 p63 (phospho Ser395) Rabbit Polyclonal Antibody 1支/RMB EnkiLife 中國 抗體

產(chǎn)品概述

產(chǎn)品名稱(Product Name)

p63 (phospho Ser395) Rabbit Polyclonal Antibody

描述(Description)

Rabbit Polyclonal Antibody

宿主(Host)

Rabbit

應(yīng)用(Application)

WB,ELISA

種屬反應(yīng)性(Reactivity)

Human,Mouse,Rat

 

產(chǎn)品性能

偶聯(lián)物(Conjugation)

Unconjugated

修飾(Modification)

Phospho Antibody

同種型(Isotype)

IgG

克?。–lonality)

Polyclonal

形式(Form)

Liquid

存放說明(Storage)

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

儲(chǔ)存溶液(Buffer)

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

純化方式(Purification)

Affinity purification

 

免疫原

基因名(Gene Name)

TP63

別名(Alternative Names)

TP63; KET; P63; P73H; P73L; TP73L; Tumor protein 63; p63; Chronic ulcerative stomatitis protein; CUSP; Keratinocyte transcription factor KET; Transformation-related protein 63; TP63; Tumor protein p73-like; p73L; p40; p51

基因ID(Gene ID)

8626

蛋白ID(SwissProt ID)

Q9H3D4

 

產(chǎn)品應(yīng)用

稀釋比(Dilution Ratio)

WB 1:500-1:2000, ELISA 1:40000.Not yet tested in other applications.

蛋白分子量(Molecular Weight)

77kDa

 

研究背景

tumor protein p63(TP63) Homo sapiens This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimcofactor:Binds 1 zinc ion per subunit.,disease:Defects in TP63 are a cause of cervical, colon, head and neck, lung and ovarian cancers.,disease:Defects in TP63 are a cause of ectodermal dysplasia Rapp-Hodgkin type (EDRH) [MIM:129400]; also called Rapp-Hodgkin syndrome or anhidrotic ectodermal dysplasia with cleft lip/palate. Ectodermal dysplasia defines a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. EDRH is characterized by the combination of anhidrotic ectodermal dysplasia, cleft lip, and cleft palate. The clinical syndrome is comprised of a characteristic facies (narrow nose and small mouth), wiry, slow-growing, and uncombable hair, sparse eyelashes and eyebrows, obstructed lacrimal puncta/epiphora, bilateral stenosis of external auditory canals, microsomia, hypodontia, cone-shaped incisors, enamel hypoplasia, dystrophic nails, and cleft lip/cleft palate.,disease:Defects in TP63 are the cause of acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) [MIM:103285]; a form of ectodermal dysplasia. Ectodermal dysplasias (EDs) constitute a heterogeneous group of developmental disorders affecting tissues of ectodermal origin. EDs are characterized by abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ADULT syndrome involves ectrodactyly, syndactyly, finger- and toenail dysplasia, hypoplastic breasts and nipples, intensive freckling, lacrimal duct atresia, frontal alopecia, primary hypodontia, and loss of permanent teeth. ADULT differs significantly from EEC3 syndrome by the absence of facial clefting.,disease:Defects in TP63 are the cause of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) [MIM:106260]. AEC is an autosomal dominant condition characterized by congenital ectodermal dysplasia with coarse, wiry, sparse hair, dystrophic nails, slight hypohidrosis, scalp infections, ankyloblepharon filiforme adnatum, maxillary hypoplasia, hypodontia and cleft lip/palate.,disease:Defects in TP63 are the cause of ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292]. EEC3 is an autosomal dominant syndrome characterized by ectrodactyly of hands and feet, ectodermal dysplasia and facial clefting.,disease:Defects in TP63 are the cause of limb-mammary syndrome (LMS) [MIM:603543]. LMS is characterized by ectrodactyly, cleft palate and mammary-gland abnormalities.,disease:Defects in TP63 are the cause of non-syndromic orofacial cleft type 8 (OFC8) [MIM:129400]. Non-syndromic orofacial cleft is a common birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum.,disease:Defects in TP63 are the cause of split-hand/foot malformation 4 (SHFM4) [MIM:605289]. Split-hand/split-foot malformation is a limb malformation involving the central rays of the autopod and presenting with syndactyly, median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals. There is restricted overlap between the mutational spectra of EEC3 and SHFM4.,domain:The transactivation inhibitory domain (TID) can interact with, and inhibit the activity of the N-terminal transcriptional activation domain of TA*-type isoforms.,function:Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of TP53/p53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge.,PTM:May be sumoylated.,similarity:Belongs to the p53 family.,similarity:Contains 1 SAM (sterile alpha motif) domain.,subunit:Binds DNA as a homotetramer. Isoform composition of the tetramer may determine transactivation activity. Isoforms Alpha and Gamma interact with HIPK2. Interacts with SSRP1, leading to stimulate coactivator activity.,tissue specificity:Widely expressed, notably in heart, kidney, placenta, prostate, skeletal muscle, testis and thymus, although the precise isoform varies according to tissue type. Progenitor cell layers of skin, breast, eye and prostate express high levels of DeltaN-type isoforms. Isoform 10 is predominantly expressed in skin squamous cell carcinomas, but not in normal skin tissues.,

 

研究領(lǐng)域

關(guān)鍵字: TP63;p63;(phospho;Ser395);Rabbit;Polyclonal;Antibody;一抗

公司簡介

武漢恩璣生命科技有限公司(EnkiLife)是一家深耕生命科學(xué),專注細(xì)胞生物學(xué)和免疫學(xué)科研試劑的研發(fā)、生產(chǎn)與銷售的生物技術(shù)企業(yè),在全球100多個(gè)國家和地區(qū)開展業(yè)務(wù),致力于為科研工作者提供高質(zhì)量的產(chǎn)品和卓越的客戶服務(wù),推動(dòng)生命科學(xué)的發(fā)展。 EnkiLife的產(chǎn)品線涵蓋細(xì)胞系、原代細(xì)胞、細(xì)胞培養(yǎng)基、血清、細(xì)胞檢測(cè)試劑盒、重組靶點(diǎn)蛋白、細(xì)胞因子、重組抗體、ELISA試劑盒、生化試劑盒等,并提供技術(shù)服務(wù)與定制開發(fā),覆蓋了生命科學(xué)研究的各大關(guān)鍵領(lǐng)域,包括細(xì)胞生物學(xué)、癌癥、免疫學(xué)、神經(jīng)科學(xué)、心血管疾病、干細(xì)胞、表觀遺傳學(xué)、內(nèi)分泌、蛋白質(zhì)組學(xué)、代謝組學(xué)等,全方位滿足您的實(shí)驗(yàn)需求,讓您享受科研的樂趣! 公司現(xiàn)已建立四大技術(shù)平臺(tái): EnCyto?細(xì)胞培養(yǎng)及檢測(cè)平臺(tái):擁有細(xì)胞系庫(500+)、原代細(xì)胞庫(500+)、基礎(chǔ)培養(yǎng)基和完全培養(yǎng)基(1200+) EnkiPro?重組蛋白平臺(tái):現(xiàn)貨產(chǎn)品2000+,可提供定制化表達(dá)服務(wù) EnAb?重組抗體平臺(tái):重組兔單抗(3000+),可提供定制化和標(biāo)記服務(wù) EnKits?試劑盒開發(fā)平臺(tái):可提供優(yōu)質(zhì)的ELISA試劑盒、配套試劑、抗體對(duì)、生化試劑盒等相關(guān)產(chǎn)品 EnkiLife在生產(chǎn)管理方面引入ISO9001質(zhì)量管理體系和信息化、自動(dòng)化的管理工具,擁有高效穩(wěn)定的交付能力,與全球知名品牌建立了緊密的合作。 EnkiLife始終堅(jiān)持以技術(shù)創(chuàng)新為驅(qū)動(dòng),以匠心鑄就品質(zhì),以品質(zhì)服務(wù)客戶。 我們期待與更多的全球科研工作者和企業(yè)攜手合作,共同推動(dòng)生命科學(xué)領(lǐng)域的進(jìn)步與發(fā)展。
成立日期 2024-08-02 (2年) 注冊(cè)資本 271萬人民幣
員工人數(shù) 10-50人 年?duì)I業(yè)額 ¥ 100萬-300萬
主營行業(yè) 生化試劑,抗體,細(xì)胞培養(yǎng),癌癥研究,細(xì)胞生物學(xué) 經(jīng)營模式 工廠,試劑,定制,服務(wù)
  • 武漢恩璣生命科技有限公司
VIP 1年
  • 公司成立:2年
  • 注冊(cè)資本:271萬人民幣
  • 企業(yè)類型:有限責(zé)任公司(自然人投資或控股)
  • 主營產(chǎn)品:細(xì)胞系/原代細(xì)胞/培養(yǎng)基/基因編輯/功能檢測(cè);重組蛋白/抗體;標(biāo)記試劑盒;WB/IHC/TSA/ELISA試劑盒
  • 公司地址:東湖新技術(shù)開發(fā)區(qū)高新大道666號(hào)C6棟
詢盤

p63 (phospho Ser395) Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩璣生命相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
¥4543
武漢艾美捷科技有限公司
2026-06-09
詢價(jià)
碧云天生物技術(shù)有限公司
2026-06-09
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的
主頁 | 企業(yè)會(huì)員服務(wù) | 廣告業(yè)務(wù) | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學(xué)品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 |投訴中心
Copyright ? 2008 ChemicalBook 京ICP備07040585號(hào)  京公海網(wǎng)安備110108000080號(hào)  All rights reserved.
大连市| 霍城县| 逊克县| 孝昌县| 泸溪县| 阿荣旗| 康乐县| 合山市| 南平市| 桓仁| 定西市| 兰考县| 买车| 虞城县| 陕西省| 七台河市| 朝阳区| 安达市| 都江堰市| 富蕴县| 法库县| 武平县| 青冈县| 大庆市| 沁源县| 文登市| 黑水县| 伊宁县| 沙湾县| 项城市| 阿拉尔市| 白玉县| 大安市| 海晏县| 长丰县| 宜兰市| 黄山市| 宝鸡市| 东宁县| 沁阳市| 米易县|